Calliditas Therapeutics: Investigator Initiated Study (IIS) and Independent Medical Education (IME) Grants
Calliditas Therapeutics is dedicated to expanding treatment options and establishing new standards of care for patients with rare diseases. Part of our mission is to further the advancement of medicine and healthcare via support for Investigator Initiated Study (IIS) and Independent Medical Education (IME).